Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

RTTNews | 784 days ago
Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

(RTTNews) - Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Tuesday that the Company's Board of Directors has appointed Eliot Richard Forster to serve on the Board of Directors as its Chairman, effective as of September 14, 2023.

In addition to Forster's appointment as Chairman and an independent director, he was also appointed to serve on the Company's Nominating Committee. Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.

Forster currently serves as the Non-Executive Chairman of Avacta Group PLC (AVCT), as a Non-Executive Director of Immatics NV (IMTX) and as the Non-Executive Chairman of Ochre Bio, Inc., a private biotechnology company.

Forster served as the Chief Executive Officer of F-Star Therapeutics Ltd., a clinical-stage bispecific antibodies company, until its March 2023 sale to inovoX Ltd. Prior to that, he served as CEO of Immunocure Ltd., CEO of Creabilis SA and President and CEO of Solace Pharmaceuticals Inc., each of which was a privately-held life science company.

Earlier in his career, he held positions at Pfizer Global Research & Development and Glaxo/GlaxoWellcome.

read more
Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending marketing authorization for PRX-102 (pegunigalsidase alfa), the first and only pegylated enzyme for the treatment of adult patients with Fabry disease.
RTTNews | 984 days ago
Australian Market Extends Early Losses In Mid-market

Australian Market Extends Early Losses In Mid-market

The Australian stock market is extending its early losses in mid-market moves on Wednesday, adding to the losses in the previous session, with the benchmark S&P/ASX 200 falling well below the 8,800 level, following the broadly negative cues from Wall Street overnight, dragged by tumbling mining, energy and technology stocks.
RTTNews | 1h 22min ago
Asian Markets A Sea Of Red

Asian Markets A Sea Of Red

Asian stock markets are a sea of red on Wednesday, following the broadly negative cues from Wall Street overnight, dragged by the benchmark indexes in Japan and South Korea which are plunging 4 to 5 percent each on concerns over stretched valuations as global tech stocks tumble on fears that an AI bubble is about to burst. Asian markets closed mostly lower on Tuesday.
RTTNews | 1h 41min ago
No Help Yet For Thai Stock Market

No Help Yet For Thai Stock Market

The Thai stock market has moved lower in four straight sessions, slumping more than 15 points or 1.1 percent along the way. The Stock Exchange of Thailand now sits just shy of the 1,300-point plateau and it's expected to open in the red again on Wednesday.
RTTNews | 2h 47min ago
Indonesia Shares Tipped To Open In The Red

Indonesia Shares Tipped To Open In The Red

The Indonesia stock market has finished lower in two of three trading days since the end of the two-day winning streak in which it had picked up almost 100 points or 1.2 percent. The Jakarta Composite Index now sits just above the 8,240-point plateau and the losses may accelerate on Wednesday.
RTTNews | 3h 17min ago
Japanese Market Sharply Lower

Japanese Market Sharply Lower

The Japanese stock market is trading sharply lower on Wednesday, extending the losses in the previous four sessions, following the broadly negative cues from Wall Street overnight. The Nikkei 225 is tumbling nearly 3 percent to below the 50,050 level, with weakness across most sectors led by index heavyweights and technology stocks.
RTTNews | 3h 25min ago